{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:48:27Z","timestamp":1769564907290,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971464"],"award-info":[{"award-number":["81971464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971464"],"award-info":[{"award-number":["81971464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM201512019"],"award-info":[{"award-number":["SZSM201512019"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chromosomal structural variations (CSVs) that comprise multiple gene mutations are important determinants for multiple diseases. However, the relationship between CSVs, rheumatoid arthritis (RA), and lung cancer is not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this study, we analyzed CSV associations and differences between RA and RA with lung cancer (RA LC) using genome sequencing, with RA-associated interstitial lung disease (RA ILD) as a disease control. First, we analyzed the CSVs of each individual. Then, we identified common CSVs within each disease group and finally analyzed specific CSVs between different diseases. Gene Ontology\/KEGG terms, canonical pathways, and feature gene sets were used for the functional annotation and analysis of CSV-related pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cell size regulation and axon guidance were mutated in all disease groups. Protein deubiquitination was mutated in RA LC, while the negative regulation of extractable stroma and protein catabolism was mutated in RA ILD. Characterization of clinical data also revealed correlations with these specific pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies common and specific CSVs and associated pathways for RA, LC, and ILD, uncovering key genetic factors that provide new insights into their diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-025-02273-7","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:55:52Z","timestamp":1766519752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chromosome structural variation analysis reveals lung cancer-associated gene regulatory networks in rheumatoid arthritis patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Heng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nini","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"2273_CR1","doi-asserted-by":"crossref","unstructured":"Seror R, Fautrel B, Lafourcade A, De-Rycke Y, Mariette X, Tubach F. Op0124\u2005Risk Of Malignancies Across Biologic Classes In Rheumatoid Arthritis: Analysis Of A National Claim Database.\u00a0Ann Rheum Dis. 2020;79:81-82.","DOI":"10.1136\/annrheumdis-2020-eular.3687"},{"key":"2273_CR2","doi-asserted-by":"crossref","unstructured":"Zhang L, Qiliang Z, Yuan F. Liu Min: Lung cancer in patients with and without rheumatoid arthritis: A propensity score-matched survival analysis cohort study.\u00a0Thorac\u00a0Cancer. 2020;11(6):1406-13.","DOI":"10.1111\/1759-7714.13388"},{"issue":"13","key":"2273_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"1","key":"2273_CR4","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170(1):Itc1\u201316.","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"2273_CR5","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","volume":"4","author":"J Silman Alan","year":"2002","unstructured":"Silman Alan J, Pearson Jacqueline E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):S265\u201372.","journal-title":"Arthritis Res"},{"issue":"9285","key":"2273_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet (London England). 2001;358(9285):903\u201311.","journal-title":"Lancet (London England)"},{"issue":"9746","key":"2273_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet (London England). 2010;376(9746):1094\u2013108.","journal-title":"Lancet (London England)"},{"key":"2273_CR8","doi-asserted-by":"crossref","unstructured":"Lopez-Olivo MA, Volk R, Krause KJ, Suarez-Almazor M. Ab0253\u2005A review of smoking cessation strategies and lung cancer screening practices in patients with rheumatoid arthritis.\u00a0Ann Rheum Dis. 2020;79:1426.","DOI":"10.1136\/annrheumdis-2020-eular.4751"},{"issue":"5","key":"2273_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2014-205847","volume":"75","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Lee EB, Kaplan IV, Kwok K, Geier J, Benda B, Soma K, Wang L, Riese R. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme. Ann Rheum Dis. 2016;75(5):831\u201341.","journal-title":"Ann Rheum Dis"},{"key":"2273_CR10","doi-asserted-by":"crossref","unstructured":"Chatzidionysiou K, di Giuseppe D, Soderling J, Catrina A, Askling J. Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking. RMD open. 2022;8(2):e002465.","DOI":"10.1136\/rmdopen-2022-002465"},{"issue":"23","key":"2273_CR11","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"2","key":"2273_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/rheumatology\/keu323","volume":"55","author":"A Yarwood","year":"2016","unstructured":"Yarwood A, Huizinga TW, Worthington J. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. Rheumatology (Oxford). 2016;55(2):199\u2013209.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2273_CR13","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","volume":"59","author":"LE Dedmon","year":"2020","unstructured":"Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology (Oxford, England). 2020;59(10):2661\u201370.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"3S","key":"2273_CR14","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.semarthrit.2019.09.007","volume":"49","author":"A Suzuki","year":"2019","unstructured":"Suzuki A, Terao C, Yamamoto K. Linking of genetic risk variants to disease-specific gene expression via multi-omics studies in rheumatoid arthritis. Semin Arthritis Rheum. 2019;49(3S):S49\u201353.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"2273_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/ard.2007.077099","volume":"67","author":"PG Bronson","year":"2008","unstructured":"Bronson PG, Criswell LA, Barcellos LF. The MHC2TA -168A\/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis. 2008;67(7):933\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2273_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/art.39591","volume":"68","author":"A Juli\u00e0","year":"2016","unstructured":"Juli\u00e0 A, Blanco F, Fern\u00e1ndez-Gutierrez B, Gonz\u00e1lez A, Ca\u00f1ete JD, Maym\u00f3 J, et al. Identification of IRX1 as a risk locus for rheumatoid factor positivity in rheumatoid arthritis in a genome-wide association study. Arthritis Rheum. 2016;68(6):1384\u201391.","journal-title":"Arthritis Rheum"},{"issue":"16","key":"2273_CR17","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.2015.3435","volume":"313","author":"S Viatte","year":"2015","unstructured":"Viatte S, Plant D, Han B, Fu B, Yarwood A, Thomson W, et al. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA. 2015;313(16):1645\u201356.","journal-title":"JAMA"},{"issue":"4","key":"2273_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/annrheumdis-2018-213678","volume":"78","author":"Y Okada","year":"2019","unstructured":"Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K. Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. 2019;78(4):446\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2273_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ajhg.2016.06.019","volume":"99","author":"Y Okada","year":"2016","unstructured":"Okada Y, Suzuki A, Ikari K, Terao C, Kochi Y, Ohmura K, et al. Contribution of a non-classical HLA gene, HLA-DOA, to the risk of rheumatoid arthritis. Am J Hum Genet. 2016;99(2):366\u201374.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2273_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1086\/422827","volume":"75","author":"AB Begovich","year":"2004","unstructured":"Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004;75(2):330\u20137.","journal-title":"Am J Hum Genet"},{"key":"2273_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.0105-2896.2005.00243.x","volume":"204","author":"PK Gregersen","year":"2005","unstructured":"Gregersen PK. Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond. Immunol Rev. 2005;204:74\u201386.","journal-title":"Immunol Rev"},{"issue":"10","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/ard.2010.144576","volume":"70","author":"P Danoy","year":"2011","unstructured":"Danoy P, Wei M, Johanna H, Jiang L, He D, Sun L, Zeng X, Visscher PM, Brown MA, Xu H. Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Ann Rheum Dis. 2011;70(10):1793\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2273_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/art.38353","volume":"66","author":"L Jiang","year":"2014","unstructured":"Jiang L, Yin J, Ye L, Yang J, Hemani G, Liu AJ, et al. Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol. 2014;66(5):1121\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"7488","key":"2273_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376\u201381.","journal-title":"Nature"},{"key":"2273_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2119\/molmed.2014.00252","volume":"21","author":"J Freudenberg","year":"2015","unstructured":"Freudenberg J, Gregersen P, Li W. Enrichment of genetic variants for rheumatoid arthritis within T-cell and NK-cell enhancer regions. Mol Med (Cambridge Mass). 2015;21:180\u20134.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"10","key":"2273_CR26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/ng.218","volume":"40","author":"A Barton","year":"2008","unstructured":"Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Plant D, Gibbons LJ, Consortium. YEAR. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet. 2008;40(10):1156\u20139.","journal-title":"Nat Genet"},{"issue":"12","key":"2273_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa073491","volume":"357","author":"RM Plenge","year":"2007","unstructured":"Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis\u2013a genomewide study. N Engl J Med. 2007;357(12):1199\u2013209.","journal-title":"N Engl J Med"},{"issue":"3","key":"2273_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/ard.2009.109447","volume":"69","author":"NA Patsopoulos","year":"2010","unstructured":"Patsopoulos NA, Ioannidis JP. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis. Ann Rheum Dis. 2010;69(3):561\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2273_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","volume":"357","author":"EF Remmers","year":"2007","unstructured":"Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, de Bakker PI, Le JM, Lee HS, Batliwalla F, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357(10):977\u201386.","journal-title":"N Engl J Med"},{"issue":"1","key":"2273_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"daW Huang","year":"2009","unstructured":"Huang daW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"D1","key":"2273_CR31","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"key":"2273_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2013.10.005","volume":"26","author":"SI van Kasteren","year":"2014","unstructured":"van Kasteren SI, Overkleeft H, Ovaa H, Neefjes J. Chemical biology of antigen presentation by MHC molecules. Curr Opin Immunol. 2014;26:21\u201331.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"2273_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479\u201392.","journal-title":"Semin Nephrol"},{"issue":"7","key":"2273_CR34","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4049\/jimmunol.1402956","volume":"194","author":"JL Giles","year":"2015","unstructured":"Giles JL, Choy E, van den Berg C, Morgan BP, Harris CL. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J Immunol. 2015;194(7):3029\u201334.","journal-title":"J Immunol"},{"issue":"5","key":"2273_CR35","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107 J, B\u00f6ttcher M, Reinwald C, Bruns H, Wirth B, Popp SJ, Walker KI, Ackermann JA, Chen X, Turner J, et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity. 2021;54(5):1002\u2013e10211010.","journal-title":"Immunity"},{"issue":"3","key":"2273_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/ard.47.3.190","volume":"47","author":"M Doherty","year":"1988","unstructured":"Doherty M, Richards N, Hornby J, Powell R. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis. 1988;47(3):190\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2273_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.autrev.2011.04.012","volume":"10","author":"E Ballanti","year":"2011","unstructured":"Ballanti E, Perricone C, Muzio Gdi, Kroegler B, Chimenti MS, Graceffa D, Perricone R. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors. Autoimmun Rev. 2011;10(10):617\u201323.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2273_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","volume":"52","author":"LK Mercer","year":"2013","unstructured":"Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, et al. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford, England). 2013;52(1):91\u20138.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"2273_CR39","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/art.27402","volume":"62","author":"K Hellgren","year":"2010","unstructured":"Hellgren K, Smedby KE, Feltelius N, Baecklund E, Askling J. Do rheumatoid arthritis and lymphoma share risk factors? A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis. Arthritis Rheum. 2010;62(5):1252\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2273_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2012-201969","volume":"72","author":"L Dreyer","year":"2013","unstructured":"Dreyer L, Mellemkj\u00e6r L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T, et al. Incidences of overall and site specific cancers in TNF\u03b1 inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO registry. Ann Rheum Dis. 2013;72(1):79\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2273_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"A Simon Teresa","year":"2015","unstructured":"Simon Teresa A, Adam T, Gandhi Kunal K, Hochberg Marc C, Samy S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. 2015;17(1):212\u2013212.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2273_CR42","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/ar2404","volume":"10","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10(2):R45.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2273_CR43","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1038\/s41467-021-25032-5","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Xu G, Wang B, Liu Y, Zhang L, Jing T, et al. USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nat Commun. 2021;12(1):4852.","journal-title":"Nat Commun"},{"key":"2273_CR44","doi-asserted-by":"publisher","first-page":"e3078","DOI":"10.7717\/peerj.3078","volume":"5","author":"R Hao","year":"2017","unstructured":"Hao R, Du H, Guo L, Tian F, An N, Yang T, Wang C, Wang B, Zhou Z. Identification of dysregulated genes in rheumatoid arthritis based on bioinformatics analysis. PeerJ. 2017;5:e3078.","journal-title":"PeerJ"},{"issue":"46","key":"2273_CR45","doi-asserted-by":"publisher","first-page":"23854","DOI":"10.1074\/jbc.M116.738518","volume":"291","author":"K Maruyama","year":"2016","unstructured":"Maruyama K, Kawasaki T, Hamaguchi M, Hashimoto M, Furu M, Ito H, et al. Bone-protective functions of Netrin 1 protein. J Biol Chem. 2016;291(46):23854\u201368.","journal-title":"J Biol Chem"},{"issue":"5","key":"2273_CR46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jbmr.2421","volume":"30","author":"A Mediero","year":"2015","unstructured":"Mediero A, Ramkhelawon B, Perez-Aso M, Moore KJ, Cronstein BN. Netrin-1 is a critical autocrine\/paracrine factor for osteoclast differentiation. J Bone Miner Res. 2015;30(5):837\u201354.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2273_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203\u201316.","journal-title":"Nat Rev Immunol"},{"key":"2273_CR48","doi-asserted-by":"crossref","unstructured":"Usman K, Hsieh A, Hackett TL. The role of MiRNAs in extracellular matrix repair and chronic fibrotic lung diseases. Cells. 2021;10(7):1706.","DOI":"10.3390\/cells10071706"},{"key":"2273_CR49","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/CMAR.S187317","volume":"11","author":"T Lu","year":"2019","unstructured":"Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943\u201353.","journal-title":"Cancer Manag Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02273-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:04:23Z","timestamp":1769519063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02273-7","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shenzhen People\u2019s Hospital, the second clinical medical college (LL-KY-2022158-01), Jinan University, China, and was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}